202 related articles for article (PubMed ID: 27677902)
1. Endemic impact of human T cell leukemia virus type 1 screening in bone allografts.
Ishidou Y; Matsuyama K; Matsuura E; Setoguchi T; Nagano S; Kakoi H; Hirotsu M; Kawamura I; Yamamoto T; Komiya S
Cell Tissue Bank; 2016 Dec; 17(4):555-560. PubMed ID: 27677902
[TBL] [Abstract][Full Text] [Related]
2. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
Satake M; Yamaguchi K; Tadokoro K
J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
[TBL] [Abstract][Full Text] [Related]
3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
Karimi G; Zadsar M; Pourfathollah AA
Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
[TBL] [Abstract][Full Text] [Related]
5. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.
Satake M; Iwanaga M; Sagara Y; Watanabe T; Okuma K; Hamaguchi I
Lancet Infect Dis; 2016 Nov; 16(11):1246-1254. PubMed ID: 27567105
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
7. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
[TBL] [Abstract][Full Text] [Related]
8. Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.
Sagara Y; Iwanaga M; Morita M; Sagara Y; Nakamura H; Hirayama H; Irita K
J Med Virol; 2018 Oct; 90(10):1658-1665. PubMed ID: 29900555
[TBL] [Abstract][Full Text] [Related]
9. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
10. Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.
Toro C; Benito R; Aguilera A; Bassani S; Rodríguez C; Calderón E; Caballero E; Alvarez P; García J; Rodríguez-Iglesias M; Guelar A; del Romero J; Soriano V;
J Med Virol; 2005 Jun; 76(2):268-70. PubMed ID: 15834870
[TBL] [Abstract][Full Text] [Related]
11. Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan.
Yoshizumi T; Takada Y; Shirabe K; Kaido T; Hidaka M; Honda M; Ito T; Shinoda M; Ohdan H; Kawagishi N; Sugawara Y; Ogura Y; Kasahara M; Kubo S; Taketomi A; Yamashita N; Uemoto S; Yamaue H; Miyazaki M; Takada T; Maehara Y
J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):333-41. PubMed ID: 26996829
[TBL] [Abstract][Full Text] [Related]
12. HTLV-I seroprevalence in patients with undefined uveitis in central Japan.
Goto K; Saeki K; Kurita M; Iijima Y; Miyake A; Ohno S
Jpn J Ophthalmol; 1994; 38(2):175-7. PubMed ID: 7967209
[TBL] [Abstract][Full Text] [Related]
13. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
14. Declining trends in HTLV-I prevalence among blood donors in Japan.
Yamaguchi K
Intern Med; 2001 Jan; 40(1):1-2. PubMed ID: 11201361
[No Abstract] [Full Text] [Related]
15. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
[TBL] [Abstract][Full Text] [Related]
16. Age and gender specific prevalence of HTLV-1.
Eshima N; Iwata O; Iwata S; Tabata M; Higuchi Y; Matsuishi T; Karukaya S
J Clin Virol; 2009 Jun; 45(2):135-8. PubMed ID: 19386541
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank.
Arjmand B; Aghayan SH; Goodarzi P; Farzanehkhah M; Mortazavi SM; Niknam MH; Jafarian A; Arjmand F; Jebelly far S
Cell Tissue Bank; 2009 Aug; 10(3):247-52. PubMed ID: 19037751
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
19. Screening blood products for HTLV-I: what is the best approach?
Vesilind GW; Koepke JA; DesHarnais GR
Transfus Sci; 1990; 11(1):103-12. PubMed ID: 10149525
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of human T-lymphotropic virus HTLV and its associated factors in donors of a blood bank of Medellín-Colombia, 2014-2018.
Cardona-Arias JA; Vélez-Quintero C; Calle-González OV; Florez-Duque J; Zapata JC
PLoS One; 2019; 14(8):e0221060. PubMed ID: 31404110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
